Online citations, reference lists, and bibliographies.
← Back to Search

Use Of And Barriers To Access To Opioid Analgesics: A Worldwide, Regional, And National Study

S. Berterame, Juliana Erthal, J. Thomas, Sarah Fellner, R. Mattick
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Despite opioid analgesics being essential for pain relief, use has been inadequate in many countries. We aim to provide up-to-date worldwide, regional, and national data for changes in opioid analgesic use, and to analyse the relation of impediments to use of these medicines. METHODS We calculated defined daily doses for statistical purposes (S-DDD) per million inhabitants per day of opioid analgesics worldwide and for regions and countries from 2001 to 2013, and we used generalised estimating equation analysis to assess longitudinal change in use. We compared use data against the prevalence of some health disorders needing opioid use. We surveyed 214 countries or territories about impediments to availability of these medicines, and used regression analyses to establish the strength of associations between impediments and use. FINDINGS The S-DDD of opioid analgesic use more than doubled worldwide between 2001-03 and 2011-13, from 1417 S-DDD (95% CI -732 to 3565; totalling about 3.01 billion defined daily doses per annum) to 3027 S-DDD (-1162 to 7215; totalling about 7.35 billion defined daily doses per annum). Substantial increases occurred in North America (16,046 S-DDD [95% CI 4032-28,061] to 31,453 S-DDD [8121-54,785]), western and central Europe (3079 S-DDD [1274-4883] to 9320 S-DDD [3969-14,672]), and Oceania (2275 S-DDD [763-3787] to 9136 S-DDD [2508-15,765]). Countries in other regions have shown no substantial increase in use. Impediments to use included an absence of training and awareness in medical professionals, fear of dependence, restricted financial resources, issues in sourcing, cultural attitudes, fear of diversion, international trade controls, and onerous regulation. Higher number of impediments reported was significantly associated with lower use (unadjusted incidence rate ratio 0.39 [95% CI 0.29-0.52]; p<0.0001), but not when adjusted for gross domestic product and human development index (0.91 [0.73-1.14]; p=0.4271). INTERPRETATION Use of opioid analgesics has increased, but remains low in Africa, Asia, Central America, the Caribbean, South America, and eastern and southeastern Europe. Identified impediments to use urgently need to be addressed by governments and international agencies. FUNDING International Narcotics Control Board, UN.
This paper references
Global Health Observatory data repository . HIV / AIDS
K Unger-Saldaña (2016)
Human development Index: Methodology and Measurement
S. Anand (1994)
10.1016/j.puhe.2011.09.032
Implications of international law for the treatment of cancer: the Single Convention on Narcotic Drugs and the TRIPS Agreement.
J. Liberman (2011)
10.1016/j.jpainsymman.2013.12.237
Cross-sectional pilot study to monitor the availability, dispensed prices, and affordability of opioids around the globe.
L. de Lima (2014)
10.1016/S0140-6736(14)60874-6
Access to controlled medicines for pain relief and anaesthesia in low-income countries
Jason W Nickerson (2014)
10.1002/pds.1833
Trends in long‐term opioid therapy for chronic non‐cancer pain
D. Boudreau (2009)
10.1002/ijc.25516
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
J. Ferlay (2010)
10.1016/j.jpainsymman.2013.03.015
Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006.
Béatrice Duthey (2014)
10.1177/0269216311398300
Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses
K. Svendsen (2011)
10.1016/j.jpainsymman.2014.10.012
Toward safe accessibility of opioid pain medicines in Vietnam and other developing countries: a balanced policy method.
E. Krakauer (2015)
10.7326/M14-2559
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
Roger Chou (2015)
10.1186/1741-7015-8-8
Access to pain treatment as a human right
D. Lohman (2010)
10.3109/15360288.2010.536307
A First Comparison Between the Consumption of and the Need for Opioid Analgesics at Country, Regional, and Global Levels
Marie-Josephine Seya (2011)
10.1016/S2214-109X(15)70154-3
Closing the pain divide: the quest for effective universal health coverage
F. Knaul (2015)
10.1093/ANNONC/MDT498
The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology.
N. Cherny (2013)
10.5306/wjco.v5.i3.465
Challenges to the early diagnosis and treatment of breast cancer in developing countries.
K. Unger-Saldaña (2014)
Trends in de-facto long-term opioid therapy for chronic non-cancer pain
D Boudreau (2009)
10.1377/hlthaff.2014.0379
Innovation can improve and expand aspects of end-of-life care in low- and middle-income countries.
Mark R Steedman (2014)
10.1093/annonc/mdt504
Next steps in access and availability of opioids for the treatment of cancer pain: reaching the tipping point?
J. Cleary (2013)
10.1016/S0140-6736(15)60791-7
The Middle East Cancer Consortium promotes palliative care
M. Silbermann (2015)
10.2307/2213979
Universal declaration of human rights
Eric Puybaret (2008)
10.1089/jpm.2015.0051
Identification of Challenges to the Availability and Accessibility of Opioids in Twelve European Countries: Conclusions from Two ATOME Six-Country Workshops.
Lisa Linge-Dahl (2015)
10.1016/S0140-6736(12)62128-X
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
H. Hogerzeil (2013)
10.1016/j.jpainsymman.2014.02.011
Opioid availability and palliative care in Nepal: influence of an international pain policy fellowship.
B. Paudel (2015)
10.1016/S0140-6736(15)61264-8
Russia's war on drugs leaves patients without pain relief
F. Clark (2015)
GLOBOCAN 2012 v 1 . 0 . Cancer incidence and mortality worldwide : IARC CancerBase No . 11
I Soerjomataram (2013)
10.1002/cam4.471
Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries
Y. Kim (2015)
10.1016/j.jpainsymman.2014.02.013
Legal barriers in accessing opioid medicines: results of the ATOME quick scan of national legislation of eastern European countries.
Marjolein J M Vranken (2014)
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer
J. Ferlay (2013)
10.1016/S0140-6736(15)60289-6
Closing the divide: the Harvard Global Equity Initiative–Lancet Commission on global access to pain control and palliative care
F. Knaul (2015)
10.1111/j.1526-4637.2011.01289.x
Advancing a national agenda to eliminate disparities in pain care: directions for health policy, education, practice, and research.
S. Meghani (2012)
10.3109/15360288.2014.941132
An Examination of Global and Regional Opioid Consumption Trends 1980–2011
B. Hastie (2014)
Human Development Index
A. Sen (2003)



This paper is referenced by
Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists
K. Paton (2018)
10.2147/JPR.S128655
Evidence and consensus recommendations for the pharmacological management of pain in India
G. P. Dureja (2017)
10.1002/bjs.11507
Risk factors and outcomes of chronic opioid use following trauma
E. von Oelreich (2020)
10.1007/s11916-018-0689-1
Global Supply and Demand of Opioids for Pain Management
S. Kunnumpurath (2018)
10.1055/a-1153-3988
Die Opioidkrise in den USA: Ausmaß, Ursachen, Gegenmaßnahmen und die europäische Situation im Vergleich
U. Preuss (2020)
10.1016/j.drugalcdep.2017.07.018
Trends in heroin and pharmaceutical opioid overdose deaths in Australia.
Amanda Roxburgh (2017)
10.1016/j.jfma.2020.09.011
Increasing tramadol utilisation under strict regulatory control of opioid prescribing - A cross-sectional study in Taiwan from 2002 through 2016.
T. Chen (2020)
10.1080/03007995.2019.1585168
Tramadol: a valuable treatment for pain in Ghana and Nigeria
Ernest Yorke (2019)
10.1111/imj.14134
Trends in adverse drug reaction‐related hospitalisations over 13 years in New South Wales, Australia
H. Zhang (2019)
10.1016/j.brainresbull.2016.04.008
How psychoactive drugs shape human culture: A multi-disciplinary perspective
G. Wadley (2016)
10.1158/1055-9965.EPI-16-0871
Global Cancer in Women: Cancer Control Priorities
F. Islami (2017)
10.1136/bmj.k2833
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
Molly M. Jeffery (2018)
Exploring the side effect profile of 16-Ethynyl Salvinorin A
Stephen George Mathew (2019)
10.1177/0269216318794091
How do expatriate health workers cope with needs to provide palliative care in humanitarian emergency assistance? A qualitative study with in-depth interviews
M. Schneider (2018)
10.31662/jmaj.2020-0037
Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan: A Preliminary Study
K. Azuma (2020)
10.3389/frvir.2020.602299
Virtual Reality Analgesia for Children With Large Severe Burn Wounds During Burn Wound Debridement
H. Hoffman (2020)
10.2147/CMAR.S290470
Practices and Hindrances in Cancer Pain Management: Results of a National Multi-Cancer Center Survey Among Healthcare Professionals in China
Cuiyun Su (2021)
10.1017/S1049023X16001035
Access to Essential Medications During Disaster Events.
Samuel J Stratton (2016)
Leveraging Machine Learning Framework To Predict Buprenorphine/naloxone Treatment Discontinuation
Prathamesh Mohite (2019)
10.4324/9780429203749-18
Behavioural approaches to managing substance-related problems in gastrointestinal conditions
Eva Maria Szigethy (2019)
10.1016/j.socscimed.2016.11.012
Common or multiple futures for end of life care around the world? Ideas from the ‘waiting room of history’
Shahaduz Zaman (2017)
10.18632/oncotarget.18681
Evaluation of a community-based integrated heroin addiction treatment model in Chinese patients.
Hong-he Zhang (2017)
10.2174/1874473711666180911091846
Pain-Prescription Differences - An Analysis of 500,000 Discharge Summaries.
S. Preissner (2019)
10.1111/ans.15976
Feasibility study of an online modifiable Enhanced Recovery After Surgery protocol with specific focus on opioid avoidance
Charlotte Ceuppens (2020)
10.1001/jamanetworkopen.2019.10734
Opioid Prescribing After Surgery in the United States, Canada, and Sweden
K. Ladha (2019)
10.1080/14737167.2018.1478291
Analysis of the drug formulary and the purchasing process at a Moroccan university medical center
Z. Lachhab (2018)
10.1136/gutjnl-2018-316001
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis
Pavit Luthra (2019)
10.2147/JPR.S162296
Tramadol: a valuable treatment for pain in Southeast Asian countries
R. Vijayan (2018)
10.1186/s12913-020-05530-w
Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007–2016
W. Jones (2020)
10.1007/s40429-018-0228-5
The Deepening Opioid Crisis in North America: Historical Context and Current Solutions
Joseph H. Donroe (2018)
10.1038/nrgastro.2017.141
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
E. Szigethy (2018)
10.1177/0003134820956332
Prescribing Habits of Providers and Risk Factors for Nonadherence to Opioid Prescribing Guidelines.
T. Ivanics (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar